MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
198.95%
Quick Ratio
194.60%
Cash Ratio
178.19%
Debt to Asset Ratio
48.40%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series e convertible preferred s...
    • Others

Balance Sheets
2026-06-30
2026-03-31
2025-12-31
Cash and cash equivalents
4,546,140 4,219,099 1,025,987
Accounts receivable, net
291,486 201,481 199,954
Inventory
111,036 104,523 116,217
Prepaid expenses and other current assets
126,961 175,174 128,975
Total current assets
5,075,623 4,700,277 1,471,133
License agreement, net
265,518 265,518 271,143
Total property and equipment
540,451 540,452 -
Less accumulated depreciation
506,751 495,265 -
Property and equipment, net
33,700 45,187 56,677
Intangible assets, gross
--243,644
Less accumulated amortization
--41,380
Intangible asset, net
205,985 206,801 202,264
Right-of-use assets, net
519,302 562,507 605,289
Deferred offering costs
--1,507,794
Other assets
23,057 23,057 23,057
Total assets
6,123,185 5,803,347 4,137,357
Accrued dividends series e convertible preferred stock
-54,192 -
Derivative liability current
0 0 143,382
Convertible notes payable current
0 306,716 74,611
Accounts payable
1,026,809 980,486 868,545
Accrued liabilities
743,001 598,335 785,784
Accrued dividends series e convertible preferred stock
121,662 54,192 -
Deferred revenue current
467,033 450,667 414,871
Operating lease liability current
192,731 189,649 175,948
Total current liabilities
2,551,236 2,580,045 2,463,141
Convertible notes payable, net
0 0 619,355
Derivative liabilities long-term
0 0 543,545
Deferred revenue long-term
32,924 37,055 41,816
Operating lease liability long term
379,717 429,122 488,725
Total long-term liabilities
412,641 466,177 1,693,441
Total liabilities
2,963,877 3,046,222 4,156,582
Series e convertible preferred stock, 0.01 par value 45,000 authorized 5,228 and 0 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively liquidation preference of 6,273,600
1,538,608 204,239 -
Preferred stock value-Series DPreferred Stock
0 0 1,016
Preferred stock value-Series CPreferred Stock
0 0 12,040
Preferred stock value-Series BPreferred Stock
0 0 14,715
Preferred stock value-Series A2Preferred Stock
0 0 4,424
Preferred stock value-Series A1Preferred Stock
0 0 6,515
Preferred stock value-Series APreferred Stock
0 0 8,464
Common stock, 0.01 par value 50,000,000 authorized 12,251,198 and 5,442,249 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
122,512 104,430 54,422
Additional paid-in capital
38,426,586 37,870,511 33,126,398
Accumulated deficit
-36,928,398 -35,422,055 -33,247,219
Total stockholders equity (deficit)
1,620,700 2,552,886 -19,225
Total liabilities, contingently redeemable preferred stock and stockholders equity
6,123,185 5,803,347 4,137,357
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,546,140 Accounts receivable, net$291,486 Prepaid expenses andother current assets$126,961 Inventory$111,036 Total property andequipment$540,451 Total current assets$5,075,623 Right-of-use assets, net$519,302 License agreement, net$265,518 Intangible asset, net$205,985 Property and equipment,net$33,700 Other assets$23,057 Less accumulateddepreciation$506,751 Total assets$6,123,185 Total liabilities,contingently redeemable...$6,123,185 Total liabilities$2,963,877 Total stockholdersequity (deficit)$1,620,700 Series e convertiblepreferred stock, 0.01 par...$1,538,608 Accumulated deficit-$36,928,398 Total currentliabilities$2,551,236 Total long-termliabilities$412,641 Additional paid-in capital$38,426,586 Common stock, 0.01 parvalue 50,000,000...$122,512 Accounts payable$1,026,809 Accrued liabilities$743,001 Deferred revenue current$467,033 Operating lease liability current$192,731 Accrued dividends series e convertible...$121,662 Operating lease liability long term$379,717 Deferred revenue long-term$32,924

20 20 Biolabs, Inc. (AIDX)

20 20 Biolabs, Inc. (AIDX)